KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strategy (MSTR) Asset Writedowns and Impairment (2016 - 2024)

Strategy (MSTR) has disclosed Asset Writedowns and Impairment for 15 consecutive years, with $18.9 million as the latest value for Q4 2024.

  • Quarterly Asset Writedowns and Impairment rose 2876.38% to $18.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $18.9 million through Sep 2025, down 97.59% year-over-year, with the annual reading at $649000.0 for FY2024, 53.21% down from the prior year.
  • Asset Writedowns and Impairment hit $18.9 million in Q4 2024 for Strategy, down from $412.1 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $917.8 million in Q2 2022 to a low of -$682.5 million in Q4 2021.
  • Historically, Asset Writedowns and Impairment has averaged $106.4 million across 5 years, with a median of $33.6 million in 2023.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 2675.57% in 2021 and later surged 912438.1% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $26.5 million in 2020, then plummeted by 2675.57% to -$682.5 million in 2021, then soared by 99.96% to -$250000.0 in 2022, then skyrocketed by 354.0% to $635000.0 in 2023, then skyrocketed by 2876.38% to $18.9 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for MSTR at $18.9 million in Q4 2024, $412.1 million in Q3 2024, and $180.1 million in Q2 2024.